Enveric Biosciences (NASDAQ: ENVB) agreed to license one of its experimental psychedelic drug candidates to MycoMedica Life Sciences in a deal worth as much as $62 million, as the biotech company keeps its eye on its non-hallucinogenic treatments. The agreement grants MycoMedica exclusive global rights to EB-002, a synthetic prodrug …
Nearly one million people in the U.S. are living with Parkinson’s Disease. Playhouse Square is rolling out a new program to help a growing number of patients.It’s important outreach because the number of cases in the U.S. is expected to rise to 1.2 million over the next five years.Last month, I circled back with the
A “weed” sign advertises a cannabis dispensary in Los Angeles. With a new Trump administration coming into the White House, marijuana could remain on …